2006
DOI: 10.1677/joe.1.06930
|View full text |Cite
|
Sign up to set email alerts
|

Phytoestrogens regulate transcription and translation of vitamin D receptor in colon cancer cells

Abstract: The present study assesses the effects of two isoflavones, genistein and glycitein, and equol -a product of intestinal bacterial metabolism of dietary isoflavones, on vitamin D receptor (VDR) expression in an intestinal HT29 cell line. Genistein and glycitein significantly upregulated the VDR transcription and translation in HT29 cells. The effect of equol was less pronounced.Treating HT29 cells transfected with a vector containing the VDR promoter next to a luciferase reporter with genistein or glycitein resu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
20
0
1

Year Published

2008
2008
2021
2021

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 38 publications
(22 citation statements)
references
References 41 publications
1
20
0
1
Order By: Relevance
“…Further studies are therefore warranted to determine the degree to which estrogen status influences VDR abundance in different 1,25(OH) 2 D 3 target tissues (i.e., breast, bone, uterus), and whether common therapeutic synthetic or natural estrogens act as estrogen agonists or antagonists in regulation of VDR expression. Consistent with this concept, some data suggests that phytoestrogens such as resveratrol and genestein can alter VDR expression and 1,25(OH) 2 D 3 sensitivity in cancer cells in vitro (Wietzke and Welsh, 2003; Gilad et al, 2006). …”
Section: Vitamin D Pathway Expression In Established Breast Cancermentioning
confidence: 87%
“…Further studies are therefore warranted to determine the degree to which estrogen status influences VDR abundance in different 1,25(OH) 2 D 3 target tissues (i.e., breast, bone, uterus), and whether common therapeutic synthetic or natural estrogens act as estrogen agonists or antagonists in regulation of VDR expression. Consistent with this concept, some data suggests that phytoestrogens such as resveratrol and genestein can alter VDR expression and 1,25(OH) 2 D 3 sensitivity in cancer cells in vitro (Wietzke and Welsh, 2003; Gilad et al, 2006). …”
Section: Vitamin D Pathway Expression In Established Breast Cancermentioning
confidence: 87%
“…A similar VDR protein upregulation in leukemia cells was observed when 1,25D was combined with other inducers or enhancers of differentiation, such as all trans retinoic acid (ATRA) [39] and bufalin [40], a major digoxin-like component of toad venom. Likewise, enhanced antiproliferative effects of 1,25D combinations with the soy isoflavone genistein [4143] or the RRR stereoisomer of α -tocopherol [44] in nonleukemic cancer cells were associated with elevated VDR expression.…”
Section: Discussionmentioning
confidence: 99%
“…This is likely due to the known property of genistein that increases half-life of vitamin D by elevating the activity of its synthesizing enzyme CYP27B1 and inhibiting the activity of CYP24 that degrades vitamin D (56). Genistein (10 μmol/L) is also shown to increase vitamin D receptor expression by binding estrogen receptor β and thus facilitate the function of vitamin D in HT29 colon cancer cells (57). Therefore, nutritional supplementation of this soy isoflavone may optimize and/or enhance the cancer-preventive effects of vitamin D.…”
Section: Dietary Modulation Of the Tgf-β Signaling Pathwaymentioning
confidence: 99%